Jeremy Levin, DPhil, MB BChir
Overview
Jeremy Levin, DPhil, MB BChir received an average of $2M in total compensation, including $554K in salary, at Ovid Therapeutics from 2017 to 2022.
Source: SEC filings on April 26, 2023, April 29, 2021, April 23, 2020, and April 24, 2019.
Related executives
We found nine more executives who work or worked at Ovid Therapeutics.
Jeffrey Rona
Ovid Therapeutics
Chief Business & Financial Officer
Jason Tardio
Ovid Therapeutics
Chief Operating Officer
Thomas Perone
Ovid Therapeutics
General Counsel
Amit Rakhit
Ovid Therapeutics
Chief Marketing Officer
Timothy Daly
Ovid Therapeutics
EVP, Finance, Corporate Controller & Treasurer
Mathew DSc
Ovid Therapeutics
Chief Scientific Officer
Jeremy Levin
Ovid Therapeutics
Chief Executive Officer
Yaron Werber
Ovid Therapeutics
Chief Business and Financial Officer and Treasurer
News
Ovid Therapeutics CEO Jeremy BChir's 2022 pay jumps 269% to $3.1M
April 26, 2023
Ovid Therapeutics CEO Jeremy BChir's 2020 pay falls 29% to $2.1M
April 29, 2021
Ovid Therapeutics CEO Jeremy BChir's 2019 pay rises 13% to $3M
April 23, 2020
Ovid Therapeutics CEO Jeremy BChir's 2018 pay jumps 25% to $2.7M
April 24, 2019